Product Overview
Curosurf 1.5ml Suspension is a medication used for the treatment of respiratory distress syndrome (RDS) in premature infants. It contains surfactant as its active ingredient, which helps to improve lung function and prevent breathing difficulties in newborns.

Key Benefits
- Reduces the risk of RDS in premature infants
- Improves lung function
- Facilitates easier breathing
- Helps prevent complications associated with respiratory distress syndrome

How It Works
Curosurf works by replacing the natural lung surfactant that is lacking in premature infants. Surfactant is essential for maintaining the elasticity of the lungs and preventing collapse of the air sacs. By administering Curosurf, the infant's lung function is improved, allowing for easier breathing and reducing the risk of complications associated with RDS.

Directions for Use
1. Ensure proper aseptic technique when handling the suspension.
2. Shake the vial gently before use to ensure uniform suspension.
3. Administer the prescribed dose of Curosurf into the endotracheal tube of the infant.
4. Monitor the infant's response to treatment and adjust dosage as necessary.

Precautions
- Use caution when administering Curosurf to infants with known allergies to surfactants.
- Monitor the infant for signs of respiratory distress or allergic reactions.
- Follow the recommended dosage and do not exceed the prescribed amount.
- Consult a healthcare professional if any adverse reactions occur.

Storage Instructions
Store Curosurf suspension in a cool, dry place away from direct sunlight. Do not freeze the medication. Keep out of reach of children.

Manufacturer Information
Curosurf 1.5ml Suspension is manufactured by Chiesi, a leading pharmaceutical company dedicated to improving the health and well-being of patients worldwide. Chiesi is committed to providing high-quality medications for the treatment of respiratory conditions and other medical needs.

Overall, Curosurf 1.5ml Suspension is a crucial medication for the management of respiratory distress syndrome in premature infants, offering significant benefits in improving lung function and reducing the risk of complications. Follow the directions for use carefully and consult a healthcare professional for any concerns or questions regarding the medication.